Compare Merck Tbk. (MERK) vs Reksa Dana Indeks Batavia IDX30 ETF (XBID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck Tbk. vs Reksa Dana Indeks Batavia IDX30 ETF — how do they compare? Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume), while Reksa Dana Indeks Batavia IDX30 ETF trades at Rp565 (market cap 15.84B, 111.8K 24h volume). The key difference: Merck Tbk. is far larger — about 110.5× Reksa Dana Indeks Batavia IDX30 ETF's market cap, and Reksa Dana Indeks Batavia IDX30 ETF is more actively traded (111.8K versus 29.1K). Which is the better fit depends on your goals.
| MERK | XBID | |
|---|---|---|
Market Cap | 1.75T | 15.84B |
Volume | 29.1K | 111.8K |
Lot | 291 | 1.12K |
Turnover | 113.37M | 50.11M |
Average Price | 3,895.98 | 448.24 |
Value | 113.37M | 50.11M |
Indicative Equilibrium Price | 3,890 | — |
Indicative Equilibrium Volume | 1 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
